Monashee Investment Management LLC Sigilon Therapeutics, Inc. Transaction History

Monashee Investment Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$2.58 - $6.13 $819,046 - $1.95 Million	-317,460 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$9.15 - $20.17 $2.9 Million - $6.4 Million	317,460 New	317,460 $3.41 Million
Q1 2021 May 14, 2021	SELL	$18.76 - $40.91 $10.5 Million - $23 Million	-561,628 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$27.6 - $48.03 $15.5 Million - $27 Million	561,628 New	561,628 $27 Million

Ticker SGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,399,300
Description
Sigilon Therapeutics, Inc., a clinical stage biotechnology company, develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neuro...

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Monashee Investment Management LLC with notifications on news.